BioLife Financial Statements From 2010 to 2025

Stocks . USA . 
Stock . BioLife Solutions
BLFS Stock  USD 24.00  0.42  1.78%   
BioLife Solutions financial statements provide useful quarterly and yearly information to potential BioLife Solutions investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on BioLife Solutions financial statements helps investors assess BioLife Solutions' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting BioLife Solutions' valuation are summarized below:
Gross Profit
55.1 M
Profit Margin
(0.31)
Market Capitalization
1.1 B
Enterprise Value Revenue
7.626
Revenue
147 M
There are over one hundred nineteen available fundamental signals for BioLife Solutions, which can be analyzed over time and compared to other ratios. All traders should validate BioLife Solutions' prevailing fundamentals against the performance from 2010 to 2025 and make sure the trends continue to evolve in the right direction. Market Cap is likely to gain to about 671.4 M in 2025. Enterprise Value is likely to gain to about 678.2 M in 2025

BioLife Solutions Total Revenue

173 Million

Check BioLife Solutions financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among BioLife Solutions' main balance sheet or income statement drivers, such as Interest Expense of 2.2 M, Selling General Administrative of 118 M or Total Revenue of 173 M, as well as many indicators such as Price To Sales Ratio of 5.42, Dividend Yield of 0.0014 or PTB Ratio of 2.3. BioLife financial statements analysis is a perfect complement when working with BioLife Solutions Valuation or Volatility modules.
  
Check out the analysis of BioLife Solutions Correlation against competitors.
For more information on how to buy BioLife Stock please use our How to Invest in BioLife Solutions guide.

BioLife Solutions Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets498.4 M474.6 M176.2 M
Slightly volatile
Other Current Liabilities22.4 M21.4 M7.3 M
Slightly volatile
Total Current Liabilities50.9 M48.5 M16.3 M
Slightly volatile
Cash42.8 M40.7 M22.4 M
Slightly volatile
Non Currrent Assets Other9.6 M9.2 M3.5 M
Slightly volatile
Other Assets466.3 M444.1 M139.4 M
Slightly volatile
Cash And Short Term Investments62.4 M59.4 M28.6 M
Slightly volatile
Common Stock Shares Outstanding52.8 M50.3 M22.3 M
Slightly volatile
Other Current Assets8.2 M7.8 M7.1 M
Slightly volatile
Other Stockholder Equity786.5 M749 M276.6 M
Slightly volatile
Total Liabilities90.6 M86.3 M31.8 M
Slightly volatile
Total Current Assets145.6 M138.7 M55.3 M
Slightly volatile
Accounts Payable8.4 M8 M4.1 M
Slightly volatile
Non Current Liabilities Total39.7 M37.8 M15.5 M
Slightly volatile
Inventory52.5 M50 M15.2 M
Slightly volatile
Net Receivables22.5 M21.5 M9.1 M
Slightly volatile
Short and Long Term Debt Total51.5 M49.1 M24.6 M
Slightly volatile
Common Stock Total Equity35.1 K38 K29.1 K
Very volatile
Short Term Debt12.1 M11.5 M4.3 M
Slightly volatile
Common Stock36.6 K51.8 K32 K
Pretty Stable
Current Deferred Revenue798.2 K760.1 K435.3 K
Slightly volatile
Property Plant Equipment56.3 M53.6 M18.2 M
Slightly volatile
Other Liabilities2.8 M3 M8.8 M
Pretty Stable
Capital Surpluse365.4 M348 M166.1 M
Slightly volatile
Deferred Long Term Liabilities47.8 M45.5 M18.5 M
Slightly volatile
Non Current Liabilities Other2 M2.1 M5.1 M
Slightly volatile
Deferred Long Term Asset Charges146.1 K132.1 K121.1 K
Very volatile
Warrants1.1 M1.2 M1.3 M
Slightly volatile
Long Term Debt Total2.3 M2.6 M2.8 M
Slightly volatile
Long Term Investments4.7 M6.5 M3.6 M
Slightly volatile
Short and Long Term Debt8.3 M7.9 M3 M
Slightly volatile
Net Invested Capital242.5 M417.2 M142.1 M
Slightly volatile
Net Working Capital65.7 M90.2 M39.5 M
Slightly volatile
Capital Stock37.2 K51.8 K27.7 K
Slightly volatile
Capital Lease Obligations14.6 M20.2 M7.1 M
Slightly volatile

BioLife Solutions Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Selling General Administrative118 M64.1 M23.4 M
Slightly volatile
Total Revenue173 M164.8 M56.7 M
Slightly volatile
Other Operating Expenses258.5 M246.2 M76.9 M
Slightly volatile
Cost Of Revenue116.5 M111 M35.8 M
Slightly volatile
Total Operating Expenses142 M135.2 M41.1 M
Slightly volatile
Research Development22.7 M21.6 M7 M
Slightly volatile
Selling And Marketing Expenses21 M22.1 M28.7 M
Slightly volatile
Interest Income63.4 K66.7 K80.1 K
Pretty Stable
Preferred Stock And Other Adjustments303.3 K389.9 K276.7 K
Slightly volatile
Reconciled Depreciation15.8 M15.1 M4.9 M
Slightly volatile
Non Recurring643.2 K601.2 K832.3 K
Slightly volatile

BioLife Solutions Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow23.5 M22.4 M17.3 M
Slightly volatile
End Period Cash Flow42.8 M40.8 M22 M
Slightly volatile
Stock Based Compensation18.7 M28.5 M21.9 M
Pretty Stable

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio5.425.7123
Slightly volatile
Dividend Yield0.00140.0020.0017
Slightly volatile
Days Sales Outstanding10754.6665.6836
Very volatile
Average Payables396.1 K630.8 K646.6 K
Very volatile
Stock Based Compensation To Revenue0.240.250.1132
Slightly volatile
EV To Sales5.475.76123
Slightly volatile
Inventory Turnover3.322.553.8138
Slightly volatile
Days Of Inventory On Hand230189167
Slightly volatile
Payables Turnover13.1412.526.498
Slightly volatile
Sales General And Administrative To Revenue0.420.450.4456
Slightly volatile
Average Inventory2.2 M2.1 M1.6 M
Slightly volatile
Research And Ddevelopement To Revenue0.140.150.1384
Pretty Stable
Capex To Revenue0.09610.05120.0856
Slightly volatile
Cash Per Share0.641.060.9203
Slightly volatile
Days Payables Outstanding28.6730.1867.5058
Slightly volatile
Intangibles To Total Assets0.30.540.4042
Slightly volatile
Current Ratio3.32.574.6726
Very volatile
Receivables Turnover8.098.836.826
Pretty Stable
Graham Number19.6218.697.497
Slightly volatile
Capex Per Share0.130.170.1113
Slightly volatile
Average Receivables1.9 M1.8 M1.5 M
Slightly volatile
Revenue Per Share3.963.771.7769
Slightly volatile
Interest Debt Per Share0.520.920.7314
Pretty Stable
Debt To Assets0.08840.09310.8879
Slightly volatile
Operating Cycle319244221
Slightly volatile
Days Of Payables Outstanding28.6730.1867.5058
Slightly volatile
Quick Ratio3.722.13.8745
Very volatile
Cash Ratio0.720.763.4037
Pretty Stable
Days Of Inventory Outstanding230189167
Slightly volatile
Days Of Sales Outstanding10754.6665.6836
Very volatile
Fixed Asset Turnover4.883.955.392
Very volatile
Debt Ratio0.08840.09310.8879
Slightly volatile
Price Sales Ratio5.425.7123
Slightly volatile
Asset Turnover0.30.310.727
Slightly volatile
Gross Profit Margin0.550.380.4781
Very volatile

BioLife Solutions Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap671.4 M639.4 M399.3 M
Slightly volatile
Enterprise Value678.2 M645.9 M391.3 M
Slightly volatile

BioLife Fundamental Market Drivers

Forward Price Earnings250
Cash And Short Term Investments51.7 M

BioLife Upcoming Events

21st of March 2024
Upcoming Quarterly Report
View
8th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
21st of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About BioLife Solutions Financial Statements

BioLife Solutions shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although BioLife Solutions investors may analyze each financial statement separately, they are all interrelated. The changes in BioLife Solutions' assets and liabilities, for example, are also reflected in the revenues and expenses on on BioLife Solutions' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue760.1 K798.2 K
Total Revenue164.8 M173 M
Cost Of Revenue111 M116.5 M
Stock Based Compensation To Revenue 0.25  0.24 
Sales General And Administrative To Revenue 0.45  0.42 
Research And Ddevelopement To Revenue 0.15  0.14 
Capex To Revenue 0.05  0.10 
Revenue Per Share 3.77  3.96 
Ebit Per Revenue(0.44)(0.47)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for BioLife Stock Analysis

When running BioLife Solutions' price analysis, check to measure BioLife Solutions' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioLife Solutions is operating at the current time. Most of BioLife Solutions' value examination focuses on studying past and present price action to predict the probability of BioLife Solutions' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioLife Solutions' price. Additionally, you may evaluate how the addition of BioLife Solutions to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY